doi:10.1007/s12250-018-0061-y

[1]
Wei-wei Gai, Yan Zhang, Di-han Zhou, Yao-qing Chen, Jing-yi Yang, Hui-min Yan, 2011: PIKA Provides an Adjuvant Effect to Induce Strong Mucosal and Systemic Humoral Immunity Against SARS-CoV^*, Virologica Sinica, 26, 81-94. doi: 10.1007/s12250-011-3183-z
[2]
Ruikun Du, Qinghua Cui, Zinuo Chen, Xiujuan Zhao, Xiaojing Lin, Lijun Rong, 2023: Revisiting influenza A virus life cycle from a perspective of genome balance, Virologica Sinica, 38, 1-8. doi: 10.1016/j.virs.2022.10.005
[3]
Hai-Yan Yan, Hui-Qiang Wang, Ming Zhong, Shuo Wu, Lu Yang, Ke Li, Yu-Huan Li, 2021: PML Suppresses Influenza Virus Replication by Promoting FBXW7 Expression, Virologica Sinica, 36, 1154-1164. doi: 10.1007/s12250-021-00399-3
[4]
Mengwei Li, Yuxu Wang, Jing Jin, Jie Dou, Qinglong Guo, Xue Ke, Changlin Zhou, Min Guo, 2021: Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo, Virologica Sinica, 36, 490-500. doi: 10.1007/s12250-020-00302-6
[5]
Shijuan Gao, Jiandong Li, Liping Song, Jiaoxiang Wu, Wenlin Huang, 2017: Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production, Virologica Sinica, 32, 261-270. doi: 10.1007/s12250-017-4004-9
[6]
Jian Chen, Jian Liu, Zhilu Chen, Daobin Feng, Cuisong Zhu, Jun Fan, Shuye Zhang, Xiaoyan Zhang, Jianqing Xu, 2023: Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells, Virologica Sinica, 38, 128-141. doi: 10.1016/j.virs.2022.12.002
[7]
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan, Li Ruan, 2019: Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats, Virologica Sinica, 34, 583-591. doi: 10.1007/s12250-019-00138-9
[8]
Xiu-ying PU, Jian-ping LIANG, Xue-hong WANG, Tao XU, Lan-ying HUA, Ruo-feng SHANG, Yu LIU, Yan-mei XING, 2009: Anti-Influenza A Virus Effect of Hypericum perforatum L. Extract ^*, Virologica Sinica, 24, 19-27. doi: 10.1007/s12250-009-2983-x
[9]
Meiyue Dong, Yanyan Wang, Ping Li, Zinuo Chen, Varada Anirudhan, Qinghua Cui, Lijun Rong, Ruikun Du, 2023: Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor, Virologica Sinica, 38, 931-939. doi: 10.1016/j.virs.2023.09.003
[10]
Yingying Yu, Qian Wang, Yanli Wei, Junwen Liu, Guangwen Wang, Zhengxiang Wang, Wentao Shen, Lu Han, Chengjun Li, Cao-Qi Lei, Shuai Xu, Qiyun Zhu, 2025: Nucleophosmin 1 inhibits the replication of influenza A virus by competitively binding viral RNA with viral proteins, Virologica Sinica, 40, 388-400. doi: 10.1016/j.virs.2025.04.007
[11]
Xiwen Zhao, Xuan Dai, Fuyi Wang, Chenyang Li, Xun Song, Yingying Han, Chaowei Zhang, Lu Wang, Zhendan He, Rongping Zhang, Liang Ye, 2025: Artemisia annua L. leaf extracts suppress influenza virus infection by targeting the viral nucleoprotein and blocking mitochondria-mediated apoptosis, Virologica Sinica, 40, 247-259. doi: 10.1016/j.virs.2025.03.001
[12]
Mingkun Wu, Liru Guo, Mei Kong, Ming Zou, Xiaochang Liu, Xiaoyan Li, 2025: Epidemiological and genomic surveillance of influenza A virus (pdm09 H1N1 and H3N2) strains from 2017 to 2025 in Tianjin, China, Virologica Sinica, 40, 535-545. doi: 10.1016/j.virs.2025.07.011
[13]
Liping Ma, Huabin Zheng, Xianliang Ke, Rui Gui, Zhongzi Yao, Jiasong Xiong, Quanjiao Chen, 2024: Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication, Virologica Sinica, 39, 56-70. doi: 10.1016/j.virs.2023.11.004
[14]
Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Yu Wei, Xia Jin, 2022: An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses, Virologica Sinica, 37, 266-276. doi: 10.1016/j.virs.2022.01.032
[15]
Shaohong Chen, Xinghai Zhang, Yanfeng Yao, Shengdong Wang, Kangyin Li, Baoyue Zhang, Tianxi Ye, Li Chen, Yan Wu, Entao Li, Bichao Xu, Pei Zhang, Xia Chuai, Yong Ran, Rui Gong, Huajun Zhang, Sandra Chiu, 2024: Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters, Virologica Sinica, 39, 909-916. doi: 10.1016/j.virs.2024.09.005
[16]
Yu Zhao, Chen Ma, Jie Yang, Xiufen Zou, Zishu Pan, 2021: Correction to: Dynamic Host Immune and Transcriptomic Responses to Respiratory Syncytial Virus Infection in a Vaccination-Challenge Mouse Model, Virologica Sinica, 36, 1684-1684. doi: 10.1007/s12250-021-00424-5
[17]
Jieliang Chen, Zhenghong Yuan, 2014: Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies, Virologica Sinica, 29, 17-24. doi: 10.1007/s12250-014-3412-3
[18]
Yu Zhao, Chen Ma, Jie Yang, Xiufen Zou, Zishu Pan, 2021: Dynamic Host Immune and Transcriptomic Responses to Respiratory Syncytial Virus Infection in a Vaccination-Challenge Mouse Model, Virologica Sinica, 36, 1327-1340. doi: 10.1007/s12250-021-00418-3
[19]
Li Yuan, Wen-Jiang Chen, Jia-Ye Wang, Yan Li, Dan Tian, Ming-Xia Wang, Hao-Tong Yu, Ying-Chu Xu, Di Li, Min Zhuang, Hong Ling, 2018: Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses, Virologica Sinica, 33, 502-514. doi: 10.1007/s12250-018-0074-6
[20]
Yunfei Wang, Jialong Qi, Han Cao, Cunbao Liu, 2021: Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice, Virologica Sinica, 36, 122-132. doi: 10.1007/s12250-020-00261-y